Prescription drug · ANDA
Amlodipine Besylate NDC 71335-0473
Amlodipine besylate 5 mg/1 · Tablet · Oral · Bryant Ranch Prepack
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71335-0473-0 | 71335047300 | 5 TABLET in 1 BOTTLE (71335-0473-0)Marketed from Sep 20, 2022 | |
| 71335-0473-1 | 71335047301 | 30 TABLET in 1 BOTTLE (71335-0473-1)Marketed from Mar 30, 2018 | |
| 71335-0473-2 | 71335047302 | 90 TABLET in 1 BOTTLE (71335-0473-2)Marketed from Mar 14, 2018 | |
| 71335-0473-3 | 71335047303 | 60 TABLET in 1 BOTTLE (71335-0473-3)Marketed from Sep 20, 2022 | |
| 71335-0473-4 | 71335047304 | 100 TABLET in 1 BOTTLE (71335-0473-4)Marketed from Apr 30, 2018 | |
| 71335-0473-5 | 71335047305 | 180 TABLET in 1 BOTTLE (71335-0473-5)Marketed from Mar 8, 2018 | |
| 71335-0473-6 | 71335047306 | 120 TABLET in 1 BOTTLE (71335-0473-6)Marketed from Sep 20, 2022 | |
| 71335-0473-7 | 71335047307 | 10 TABLET in 1 BOTTLE (71335-0473-7)Marketed from Sep 20, 2022 | |
| 71335-0473-8 | 71335047308 | 500 TABLET in 1 BOTTLE (71335-0473-8)Marketed from Sep 20, 2022 | |
| 71335-0473-9 | 71335047309 | 1000 TABLET in 1 BOTTLE (71335-0473-9)Marketed from Sep 20, 2022 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Amlodipine Besylate
- Generic name (nonproprietary)
- amlodipine besylate
- Active ingredients
- Amlodipine besylate — 5 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Bryant Ranch Prepack
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 077073
- Marketing start
- Listing expires
- Other FDA classes
- Calcium Channel Antagonists (Mechanism)Cytochrome P450 3A Inhibitors (Mechanism)Dihydropyridines (Chemical structure)
- Identifiers
- Product ID 71335-0473_422f8bd0-f200-4715-8c6d-ed6282eec810SPL ID 422f8bd0-f200-4715-8c6d-ed6282eec810SPL set ID f546047f-1cc6-4bbe-a67b-b5c9815b89afRxCUI 197361UNII 864V2Q084H
- Pharmacologic class
- Calcium Channel Blocker; Dihydropyridine Calcium Channel Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471335047300followed by a unit qualifier and the quantityPackage 71335-0473-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Amlodipine besylate tablet, USP is a calcium channel blocker and may be used alone or in combination with other antihypertensive and antianginal agents for the treatment of: • Hypertension (1.1) o Amlodipine besylate tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. • Coronary Artery Disease (1.2) o Chronic Stable Angina o Vasospastic Angina (Prinzmetal's or Variant Angina) o Angiographically Documented Coronary Artery Disease in patients without heart failure or an ejection fraction < 40% 1.1 Hypertension Amlodipine besylate tabl…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 077073
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Amlodipine Besylate | Amlodipine besylate 10 mg/1 | TabletOral | NuCare Pharmaceuticals, Inc. | 68071-1980 |
| Amlodipine Besylate | Amlodipine besylate 5 mg/1 | TabletOral | Northwind Health Company, LLC | 51655-044 |
| Amlodipine Besylate | Amlodipine besylate 5 mg/1 | TabletOral | Preferred Pharmaceuticals Inc. | 68788-8627 |
| Amlodipine Besylate | Amlodipine besylate 5 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-0835 |
| Amlodipine Besylate | Amlodipine besylate 10 mg/1 | TabletOral | Redpharm Drug | 67296-2297 |
| Amlodipine Besylate | Amlodipine besylate 10 mg/1 | TabletOral | Cipla USA Inc. | 69097-128 |
| Amlodipine Besylate | Amlodipine besylate 2.5 mg/1 | TabletOral | Cipla USA Inc. | 69097-126 |
| Amlodipine Besylate | Amlodipine besylate 5 mg/1 | TabletOral | Cipla USA Inc. | 69097-127 |
| Amlodipine Besylate | Amlodipine besylate 10 mg/1 | TabletOral | Proficient Rx LP | 63187-914 |
| Amlodipine Besylate | Amlodipine besylate 10 mg/1 | TabletOral | Bryant Ranch Prepack | 71335-0218 |
| Amlodipine Besylate | Amlodipine besylate 10 mg/1 | TabletOral | Northwind Health Company, LLC | 51655-869 |
| Amlodipine Besylate | Amlodipine besylate 2.5 mg/1 | TabletOral | PD-Rx Pharmaceuticals, Inc. | 43063-764 |
| Amlodipine Besylate | Amlodipine besylate 2.5 mg/1 | TabletOral | Quallent Pharmaceuticals Health LLC | 82009-026 |
| Amlodipine Besylate | Amlodipine besylate 10 mg/1 | TabletOral | Quallent Pharmaceuticals Health LLC | 82009-028 |
| Amlodipine Besylate | Amlodipine besylate 10 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-0297 |
| Amlodipine Besylate | Amlodipine besylate 5 mg/1 | TabletOral | Quallent Pharmaceuticals Health LLC | 82009-027 |
- openFDA data updated
Med-Code stores this record for up to 24 hours before requesting it again.
Reference information only. Verify codes and billing rules against the applicable payer and official source before submitting a claim. How Med-Code handles data.